ARTICLE | Management Tracks
Celsee’s Stark named Resolve CEO
Plus: New CEO for BioCina and updates from SeqOne and more
March 16, 2023 1:16 AM UTC
Resolve Biosciences GmbH named John Stark CEO, succeeding Jason Gammack, who will be leaving the company. Stark was CEO of Quantum-Si Inc. (NASDAQ:QSI) and, before that, CEO of Celsee Diagnostics, which was acquired by Bio-Rad Laboratories Inc. (NYSE:BIO) in 2020. Resolve’s Molecular Cartography platform includes automated and multiplexed single-molecule fluorescence in-situ hybridization (FISH) technology to detect individual RNA transcripts with subcellular resolution.
Mark Womack became CEO of BioCina Pty Ltd., succeeding founding CEO Ian Wisenberg, who is now executive chair of the CDMO. Womack served as CEO of KBI Biopharma Inc. and Selexis S.A. ...